Brief: Evolus Q4 Net Income USD -11.831 Million
07/03/2024 21:05
Mar 07 (Reuters) - Evolus Q4 gross profit USD 40.99 million. * Q4 gross margin 67.2% * Q4 adjusted gross margin 68.4% * outlook FY sales growth 26-31% * outlook FY sales USD 255-265 million
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe